Study of stomach cancer in Algeria
Part of Cancer, Digestive system clinical trials.
This study looks at how stomach cancer is diagnosed and treated in Algeria. It helps doctors learn more about the disease to improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older
- You have been diagnosed with stomach cancer confirmed by a biopsy
- You are receiving care at a participating hospital in Algeria
- You agree to take part and sign a consent form
- Your tumor is not a type like GIST, lymphoma, or sarcoma
- Your stomach cancer started in your stomach, not spread from another organ
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study looks for early warning changes in the stomach and aims to improve early detection and prevention. Depending on your situation, you may be grouped as having stomach symptoms, early lesions that might be removed, already-diagnosed stomach cancer, or a comparison group without stomach problems.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.